Sign In

Health Research Governance Department - MoPH

High Quality Research

Research Department

Text Size : -A A A+

Research News letters

T cells recognize recent SARS-CoV-2 variants
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients begins
COVID-19 vaccine responses to be studied in people with immune deficits
Researchers propose that humidity from masks may lessen severity of COVID-19
Study Identifies Risk Factors for Elevated Anxiety in Young Adults During COVID-19 Pandemic
NIH experts discuss SARS-CoV-2 viral variants
Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial
NIH calls for greater inclusion of pregnant and lactating people in COVID-19 vaccine research
Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy
NIH launches database to track neurological symptoms associated with COVID-19
Severe COVID-19 in pregnancy associated with preterm birth, other complications
Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients
Pregnant women in third trimester unlikely to pass SARS-CoV-2 infection to newborns
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection
Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine
Investigational COVID-19 therapeutics to be evaluated in large clinical trials
NIH observational study of coronavirus infection and multisystem inflammatory syndrome in children begins
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA
Baricitinib plus remdesivir shows promise for treating COVID-19
NIH-funded tool helps organizations plan COVID-19 testing
Fourth iteration of COVID-19 treatment trial underway
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
Treatments for people with early COVID-19 infection is an urgent research focus
Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19
1 - 30Next